Merck
CN
Advanced Search
Structure Search
Search Within
Document Type

286-94-2

Applied Filters:
Keyword:'286-94-2'
Showing 1-30 of 42 results for "286-94-2" within Technical Documents
Product Information Sheet - G5002
18803 Fluorescence: excitation at 286 nm, emission at 337 nm.2 STORAGE / STABILITY AS SUPPLIED: Gramicidin should be stable for at least three years stored at 2-8 °C.4 SOLUBILITY / SOLUTION STABILITY
Data Sheet - SAB4200580
2000). 2. Sakakibara, S., et al., Proc. Natl. Acad. Sci. USA, 12, 15194-15199 (2002). 3. Imai, T., et al., Mol. Cell. Biol., 21, 3888-3900 (2001). 4. Kawahara, H., et al., J. Biol. Chem., 286, 16121
Data Sheet - SAB4200710
J Cell Mol Med., 13, 262–9 (2009). 2 12. Mao YJ., et al., J Int Med Res., 38, 711-9 (2010). 13. Sasaki Y., et al., Cancer
Application Note - Universal ProbeLibrary for Quantitative Expression Analysis in Zebrafish
Christoph Leucht Biochemica · No. 2 · 2007 1717 40–50 cycles of 10 seconds at 94°C, 5 seconds at 55°C, and 5 seconds at 72°C. For all SYBR Green I assays
Product Information Sheet - C3615
63103 USA Telephone 800-325-5832 • (314) 771-5765 Fax (314) 286-7828 email: techserv@sial.com sigma-aldrich.com ProductInformation S i g m a i s a M e m b e r o f t h e
GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor
from GlaxoSmithKline. References 1. Matsuno, H., et al., J. Cardiovasc. Pharmacol., 39, 278-286 (2002). 2. Rozalski, M., et al., Biochem. Pharmacol., 62, 1399-1408 (2001). GR 144053: Non-peptide antagonist
Product Information Sheet-04693132001
Universal Protease Substrate 40 mg 11 734 334 001 Pepstatin 2 mg 10 253 286 001 10 mg 11 359 053 001 50 mg 11 524 488 001 1 2 3 1 2 3 03 21 .0 47
Data Sheet - P7122
Biol. Chem., 269, 7764-771 (1994). 6. Primm, T.F., and Gilbert, H.F., J. Biol. Chem., 276, 281-286 (2001). 7. Gao, Y., and Mehta, K., J. Biochem., 129, 179-183 (2001). 8. Essex, D.W., et al., Blood
Data Sheet - P7496
Chem., 269, 7764-771 (1994). 6. Primm, T.F., and Gilbert, H.F., J. Biol. Chem., 276, 281-286 (2001). 7. Gao, Y., and Mehta, K., J. Biochem., 129, 179- 183 (2001). 8. Essex, D.W., et al.
Quality Control Range Sheet- A6041-102and A6041-202
pg/mL Control 2 245 - 527 pg/mL Control 2 1941 - 4031 pg/mL IL-2 Control 1 27 - 56 pg/mL IL-5 Control 1
Data Sheet - P7372
Chem., 269, 7764-771 (1994). 6. Primm, T.F., and Gilbert, H.F., J. Biol. Chem., 276, 281-286 (2001). 7. Gao, Y., and Mehta, K., J. Biochem., 129, 179- 183 (2001). 8. Essex, D.W., et al.
Anti-NeuN, clone A60 - Data Sheet
Gene Therapy (1999) 6:1851-1866. 13) Gould, E., et al., Science (1999) 286:548-552. 14) Nichols, M., et al., Science (1999) 286:1558-1561. 15) Justicia, C. et al., Glia (2000) 30: 253-270. 16) Magavi
Product Information Sheet-04693159001
tablets in glass vials, for 50 ml each 05 056 489 001 Pepstatin 2 mg 10 253 286 001 10 mg 11 359 053 001 50 mg 11 524 488 001 1 2 3 1 2 3 03 21
XP725 Antibody Number-Lot Number 071M4826
234 235 236 257 258 259 260 281 282 283 284 3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288 4.1 289 290 291 292 313 314 315 316 337 338 339 340 361
Product Information Sheet - SE120032
Value Recovery (%) Neat 286 – – 1:2 138 143 96 1:4 75 72 104 1:8 37.9 36 105 1 1:16 19.5 18 108 Neat 61.8 – – 1:2 32.1 30.9 104 1:4 15.9 15.5 103 2 1:8 7.2 7.7 94
Protocol: Rat/Mouse Ghrelin (Active)
10 µL 286 101% 304 98% 5 µL 151 107% 142 92% Mouse 20 µL
Product Information Sheet-coedtaf-ro
conditions. 5.3. Ordering Information Product Pack Size Cat. No. Reagents, kits Pepstatin 2 mg 10 253 286 001 10 mg 11 359 053 001 50 mg 11 524 488 001 Universal Protease Substrate 40 mg 11 734
Product Information Sheet-11836170001
tablets, for 10 ml each 04 906 837 001 Universal Protease Substrate 40 mg 11 734 334 001 Pepstatin 2 mg 10 253 286 001 10 mg 11 359 053 001 50 mg 11 524 488 001 cOmplete, EDTA-free 20 tablets
Application Note - RealTime PCR Quantification of Plant miRNAs Using Universal ProbeLibrary Technology
reactions) 04 535 286 001 Universal ProbeLibrary Probe #21 2 vials (2 x 625 reactions of 20µl) 04 686 942 001 Order INFO Biochemica · No. 2 · 2007 1515Gene expression +RT 20 ng +RT 2
Product Information Sheet - CS0040
Measured (U/mL) Expected (U/mL) % Expected Neat 85.8 85.8 100 1:2 43.1 42.9 100 1:4 21.4 21.5 99.7 1:8 10.1 10.7 94 1:16 4.7 5.4 88 1:32 2.8 2.7 104
Product Information Sheet - PM0100
Dilution Measured (pg/mL) Expected (pg/mL) % Expected Neat 966 966 100 1:2 494 483 102 1:4 232 246 94 1:8 120 116 103 1:16 66 60 109
Product Information Sheet - 4719948001
048 001 �2-Macroglobulin 25 inhibitory units 10 602 442 001 Pefabloc® SC 100 mg 500 mg 1 g 11 429 868 001 11 585 916 001 11 429 876 001 Pepstatin 2 mg 10 mg 50 mg 10 253 286 001 11
Product Information Sheet - BE0100
Alzheimer’s amyloid precursor protein by the transmembrane aspartic Protease BACE. Science, 286, 735-741 (1999). 2. Savage, M.J., et al. Turnover of β-amyloid protein in mouse brain and acute reduction
Product Information Sheet - EK0100
1512 1512 100% 1:2 792 756 104% 1:4 344 378 91% 1:8 182 189 97% 1:16 85 94 91% References 1. Cobb, M.H. MAP kinase pathways. Prog. Biophys. Mol. Biol., 71, 479-500 (1999). 2. Cross
BE0200-Amyloid 1-42 ELISA Human AHPHC
Alzheimer’s amyloid precursor protein by the transmembrane aspartic Protease BACE. Science, 286, 735-741 (1999). 2. Savage, M.J., et al., Turnover of ß-amyloid protein in mouse brain and acute reduction
Product Information Sheet - BE0200
Alzheimer’s amyloid precursor protein by the transmembrane aspartic Protease BACE. Science, 286, 735-741 (1999). 2. Savage, M.J., et al., Turnover of β-amyloid protein in mouse brain and acute reduction
BE0100-Amyloid 1-40 ELISA Human AHPHC
Alzheimer’s amyloid precursor protein by the transmembrane aspartic Protease BACE. Science, 286, 735-741 (1999). 2. Savage, M.J., et al. Turnover of β-amyloid protein in mouse brain and acute reduction
Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy
-translational modifications. References 1. Wolffe, A.P. and Matzke, M.A., Science, 286, 481-486 (1999). 2. Gasser, S.M., et al., Cell Mol. Life Sci., 54, 1-5 (1998). 3. Kohler, C. and Grossniklaus
Protein Tyrosine Phosphatases- Potential Roles in Disease
from GlaxoSmithKline. References 1. Matsuno, H., et al., J. Cardiovasc. Pharmacol., 39, 278-286 (2002). 2. Rozalski, M., et al., Biochem. Pharmacol., 62, 1399-1408 (2001). GR 144053: Non-peptide antagonist
Protocol: Human Resistin ELISA Kit
2.53 100 2 1.16 1.27 109 4 0.60 0.64 107 8 0.32 0.32 100 2 0 1.49 1.49 100 2 0.75 0.63 84 4 0.37 0.31 84 8 0.19 0.17 89
Page 1 of 2